Galectin Therapeutics Inc.

États‑Unis d’Amérique


 
Quantité totale PI 37
Rang # Quantité totale PI 38 201
Note d'activité PI 1,4/5.0    5
Rang # Activité PI 195 344
Symbole boursier
ISIN US3632252025
Capitalisation 119M  (USD)
Industrie Drug Manufacturers - Specialty & Generic
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

19 3
5 0
7 3
0
 
Dernier brevet 2023 - Composition of novel carbohydrat...
Premier brevet 2001 - Delivery of a therapeutic agent ...
Dernière marque 2013 - GALECTIN THERAPEUTICS
Première marque 2013 - GALECTIN THERAPEUTICS GT

Industrie (Classification de Nice)

Derniers inventions, produits et services

2022 Invention Composition of novel carbohydrate drug for treatment of human diseases. Aspects of the invention...
2020 Invention Methods for treatment of arthritis. Aspects of the invention provide compositions for use in the ...
Invention Compositions comprising galactose-pronged polysaccharides. Methods and compositions for reducing...
2019 Invention Composition of novel carbohydrate drug for treatment of human diseases. Aspects of the invention ...
2018 Invention Method for enhancing specific immunotherapies in cancer treatment. Methods and compositions of th...
2017 Invention Galactose-pronged polysaccharides in a formulation for antifibrotic therapies. Methods and compos...
2016 Invention Method for treatment of pulmonary fibrosis. Methods and compositions of the invention relate to t...
2015 Invention Galactose-pronged polysaccharides in a formulation for antifibrotic therapies. Methods and compo...
2013 Invention Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated...
P/S Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohe...
Invention Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated i...
P/S Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohep...
2012 Invention Compositions of novel carbohydrate drug for treatment of human diseases. Aspects of the invention...
Invention Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and n...
Invention Galactomannan polysaccharide composition for the treatment of nonalcoholic steatohepatitis and no...
2010 Invention Selectively depolymerized galactomannan polysaccharide. Disclosed herein are compositions and me...
2008 Invention Selectively depolymerized galactomannan polysaccharide. Disclosed herein are compositions and met...
2003 Invention Delivery of a therapeutic agent in a formulation for reduced toxicity. Methods and compositions f...
2002 Invention Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer. ...
2001 Invention Methods and compositions for reducing side effects in chemotherapeutic treatments. A pharmaceutic...